Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis

Clinical and Experimental Immunology

Volumn 166, Issue 1, 2011, Pages 46-54

  Baumgart, Daniel C ^a   Metzke, D ^a   Guckelberger, O ^a   Pascher, A ^a   Grotzinger C ^a   Przesdzing, I ^a   Dorffel Y ^b   Schmitz, J ^c   Thomas, S ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Miltenyi Biotec ^*  (Germany)

Author keywords

Antigen presentation; Crohn's disease; Dendritic cells; Ulcerative colitis

Indexed keywords

ALPHA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CCR7; INTERLEUKIN 6; INTERLEUKIN 8; OLIGONUCLEOTIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CELL ISOLATION; COLON MUCOSA; CONTROLLED STUDY; CPG ISLAND; CROHN DISEASE; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MAJOR CLINICAL STUDY; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ULCERATIVE COLITIS;

ADULT; AGED; ANTIGENS, CD; COLITIS, ULCERATIVE; CROHN DISEASE; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-ALPHA; INTERLEUKIN-6; INTERLEUKIN-8; INTESTINAL MUCOSA; LYMPH NODES; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80052626409     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2011.04439.x     Document Type: Article

References (50)

1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007; 369:1641-57.
2. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369:1627-40.
3. Kelsall B. Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages. Mucosal Immunol 2008; 1:460-9.
4. Matta BM, Castellaneta A, Thomson AW. Tolerogenic plasmacytoid DC. Eur J Immunol 2010; 40:2667-76.
5. Reizis B. Regulation of plasmacytoid dendritic cell development. Curr Opin Immunol 2010; 22:206-11.
6. Swiecki M, Colonna M. Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance. Immunol Rev 2010; 234:142-62.
7. Baumgart DC, Metzke D, Schmitz J etal. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells. Gut 2005; 54:228-36.
8. D'Haens G, Sandborn WJ, Feagan BG etal. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007; 132:763-86.
9. Sandborn WJ, Feagan BG, Hanauer SB etal. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002; 122:512-30.
10. Baumgart DC, Thomas S, Przesdzing I etal. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin Exp Immunol 2009; 157:423-36.
11. Carson RT, Vignali DA. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999; 227:41-52.
12. Baumgart DC, Olivier WA, Reya T, Peritt D, Rombeau JL, Carding SR. Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice. Cell Immunol 1998; 187:52-66.
13. McLellan AD, Sorg RV, Williams LA, Hart DN. Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. Eur J Immunol 1996; 26:1204-10.
14. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184:747-52.
15. Bell SJ, Rigby R, English N etal. Migration and maturation of human colonic dendritic cells. J Immunol 2001; 166:4958-67.
16. Hart AL, Al-Hassi HO, Rigby RJ etal. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 2005; 129:50-65.
17. Ikeda Y, Akbar SM, Matsui H, Onji M. Antigen-presenting dendritic cells in ulcerative colitis. J Gastroenterol 2002; 37 (Suppl. 14):53-5.
18. Ikeda Y, Akbar F, Matsui H, Onji M. Characterization of antigen-presenting dendritic cells in the peripheral blood and colonic mucosa of patients with ulcerative colitis. Eur J Gastroenterol Hepatol 2001; 13:841-50.
19. Vuckovic S, Florin TH, Khalil D etal. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases. Am J Gastroenterol 2001; 96:2946-56.
20. Liu K, Victora GD, Schwickert TA etal. In vivo analysis of dendritic cell development and homeostasis. Science 2009; 324:392-7.
21. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. Development of monocytes, macrophages, and dendritic cells. Science 2010; 327:656-61.
22. Reizis B, Bunin A, Ghosh HS, Lewis KL, Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu Rev Immunol 2011; 29:163-83.
23. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8:594-606.
24. Krug A, French AR, Barchet W etal. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21:107-19.
25. MacDonald KP, Munster DJ, Clark GJ, Dzionek A, Schmitz J, Hart DN. Characterization of human blood dendritic cell subsets. Blood 2002; 100:4512-20.
26. Karlis J, Penttila I, Tran TB etal. Characterization of colonic and mesenteric lymph node dendritic cell subpopulations in a murine adoptive transfer model of inflammatory bowel disease. Inflamm Bowel Dis 2004; 10:834-47.
27. Wendland M, Czeloth N, Mach N etal. CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine. Proc Natl Acad Sci USA 2007; 104:6347-52.
28. Wurbel MA, McIntire MG, Dwyer P, Fiebiger E. CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis. PLoS One 2011; 6:e16442.
29. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448:427-34.
30. Targan SR, Hanauer SB, van Deventer SJ etal. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337:1029-35.
31. Ito H, Takazoe M, Fukuda Y etal. A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease. Gastroenterology 2004; 126:989-96.
32. Blumberg R. What are innate and acquired immunity, and why are they important in IBD? Inflamm Bowel Dis 2008; 14 (Suppl. 2):S93-4.
33. Rakoff-Nahoum S, Bousvaros A. Innate and adaptive immune connections in inflammatory bowel diseases. Curr Opin Gastroenterol 2010; 26:572-7.
34. Louis NA, Robinson AM, MacManus CF, Karhausen J, Scully M, Colgan SP. Control of IFN-alphaA by CD73: implications for mucosal inflammation. J Immunol 2008; 180:4246-55.
35. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005; 115:695-702.
36. Madsen SM, Schlichting P, Davidsen B etal. An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis. Am J Gastroenterol 2001; 96:1807-15.
37. Yang CH, Murti A, Valentine WJ, Du Z, Pfeffer LM. Interferon alpha activates NF-kappaB in JAK1-deficient cells through a TYK2-dependent pathway. J Biol Chem 2005; 280:25849-53.
38. Guiducci C, Gong M, Xu Z etal. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 2010; 465:937-41.
39. Aman MJ, Tretter T, Eisenbeis I etal. Interferon-alpha stimulates production of interleukin-10 in activated CD4+ T cells and monocytes. Blood 1996; 87:4731-6.
40. Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal MR, Roncarolo MG. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol 2001; 166:5530-9.
41. Wirtz S, Neurath MF. Illuminating the role of type I IFNs in colitis. J Clin Invest 2005; 115:586-8.
42. Seow CH, Benchimol EI, Griffiths AM, Steinhart AH. Type I interferons for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2008; (3):CD006790.
43. Forster R, valos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8:362-71.
44. Hopken UE, Wengner AM, Loddenkemper C etal. CCR7 deficiency causes ectopic lymphoid neogenesis and disturbed mucosal tissue integrity. Blood 2007; 109:886-95.
45. Schneider MA, Meingassner JG, Lipp M, Moore HD, Rot A. CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cells. J Exp Med 2007; 204:735-45.
46. Middel P, Raddatz D, Gunawan B, Haller F, Radzun HJ. Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism. Gut 2006; 55:220-7.
47. Sakuraba A, Sato T, Kamada N, Kitazume M, Sugita A, Hibi T. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 2009; 137:1736-45.
48. Silverberg MS, Satsangi J, Ahmad T etal. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl. A):5-36.
49. Dubois B, Joubert G, Gomez de AM, Gouanvic M, Goubier A, Kaiserlian D. Sequential role of plasmacytoid dendritic cells and regulatory T cells in oral tolerance. Gastroenterology 2009; 137:1019-28.
50. Goubier A, Dubois B, Gheit H etal. Plasmacytoid dendritic cells mediate oral tolerance. Immunity 2008; 29:464-75.